Synapse
⌘+K
Sign In
Sign Up for Free
Synapse
Sign In
Sign Up for Free
Home
Communities
Explore
More
Language
English
English
Surgimab (France)
h-index: 10
Total citations: 630
Total papers: 23
Homepage:
http://www.surgimab.com/
Recent papers from Surgimab (France)
Variation in SGM-101 fluorescence is associated with tumor biology in primary colorectal cancer and colorectal liver metastases
Surgical Oncology · 2026
Deep Brain Stimulation of the Internal Pallidum Modulates the Mesencephalic Locomotor Pathway in Improved Cervical Dystonic Patients
Movement Disorders Clinical Practice · 2026
Feasibility of Anti-CEA Dye Conjugate for Cancer-Specific Imaging in Gastric Cancer Cell Lines and Mouse Xenograft Models.
2025
Long-term Local Control Following CEA-targeted Fluorescence-guided Surgery in Patients With Locally Advanced and Recurrent Rectal Cancer
Molecular Imaging and Biology · 2025
Intraoperative molecular imaging of colorectal lung metastases with SGM-101: a feasibility study
European Journal of Nuclear Medicine and Molecular Imaging · 2023
Anti-Müllerian hormone concentration regulates activin receptor-like kinase-2/3 expression levels with opposing effects on ovarian cancer cell survival
International Journal of Oncology · 2021
Anti-Müllerian hormone (AMH) autocrine signaling promotes survival and proliferation of ovarian cancer cells
Scientific Reports · 2021
Dose-Finding Study of a CEA-Targeting Agent, SGM-101, for Intraoperative Fluorescence Imaging of Colorectal Cancer
Annals of Surgical Oncology · 2020
Multimodal CEA-Targeted Image-Guided Colorectal Cancer Surgery using 111In-Labeled SGM-101
Clinical Cancer Research · 2020
Carcinoembryonic antigen-specific, fluorescent image-guided cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for metastatic colorectal cancer
British journal of surgery · 2020
Toxicity and pharmacokinetic profile of SGM-101, a fluorescent anti-CEA chimeric antibody for fluorescence imaging of tumors in patients
Toxicology Reports · 2019
Image-Guided Surgery in Patients with Pancreatic Cancer: First Results of a Clinical Trial Using SGM-101, a Novel Carcinoembryonic Antigen-Targeting, Near-Infrared Fluorescent Agent
Annals of Surgical Oncology · 2018
SGM-101: An innovative near-infrared dye-antibody conjugate that targets CEA for fluorescence-guided surgery
Surgical Oncology · 2017